BELMONT COUNTY, Ohio — The Belmont County Board of Commissioners met Wednesday with Tate Blanchard, Chief Development Officer of IC Care, to formally recognize June as Alzheimer’s and Brain Awareness Month.
Blanchard brought attention to the growing impact of Alzheimer’s disease and other forms of dementia throughout the Upper Ohio Valley.
Blanchard emphasized the importance of advocacy, early detection, and continued support for families dealing with the effects of cognitive decline.
“It’s critically important for us to continue raising awareness. Our association provides vital resources for families and patients right here in Belmont County. Nearly 11 percent of residents over 65 are currently diagnosed with some form of dementia, and that number keeps rising every year.”
Tate Blanchard, Chief Development Officer of IC Care
Blanchard noted that thanks to aggressive lobbying efforts by the Alzheimer’s Association in 2023, three FDA-approved medications that help slow the progression of Alzheimer’s are now covered by Medicare and private insurance. Previously, these medications could cost patients as much as $30,000 to $40,000 out of pocket.
“This change has made access to life-altering treatment more equitable,” he said. It’s a massive win for patients and families.”
Tate Blanchard, Chief Development Officer of IC Care
He also addressed the emotional toll dementia takes on both patients and their loved ones.
“It doesn’t just rob the individual of who they are—it robs the family of the person they love. We care for many patients who no longer recognize their spouse or children. It’s heartbreaking.”
Tate Blanchard, Chief Development Officer of IC Care
Blanchard shared stories of individuals diagnosed with early-onset dementia as young as 45 and noted the increasing prevalence among women, with one in five women at that age already receiving a diagnosis.
He encouraged the public to watch for signs beyond typical forgetfulness—such as difficulty performing daily routines, repeated questions, or confusion about familiar environments—as potential indicators of cognitive decline.
Commissioners shared personal stories of family members who had experienced dementia, expressing gratitude for the work IC Care and the Alzheimer’s Association continue to do.
“We appreciate you coming in every year and speaking to this with such passion and knowledge. This affects so many of us.”
Commissioner J.P. Dutton
Blanchard concluded by urging families to seek medical attention early if they notice changes in a loved one, emphasizing that timely diagnosis and intervention can make a meaningful difference.
